C 
784
-2.61%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩27.39bn
FY2016FY2025
Net income
−₩3.52bn
FY2016FY2025
Free cash flow
−₩25.41bn
FY2016FY2025
Shareholders' equity
₩105.15bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩27.39bn | ₩7.25bn | ₩4.88bn | ₩4.32bn | ₩42.38bn | ₩30.22bn | ₩14.01bn | ₩13.89bn | ₩12.18bn | ₩14.52bn |
| Research and development | ₩4.42bn | ₩11.32bn | ₩7.18bn | ₩6.34bn | ₩4.86bn | ₩4.98bn | — | ₩3.43bn | ₩7.54bn | ₩7.07bn |
| Operating income | −₩26.10bn | −₩54.97bn | −₩15.98bn | −₩24.42bn | −₩24.29bn | ₩7.92bn | −₩16.82bn | ₩1.03bn | −₩6.71bn | −₩4.09bn |
| Net income | −₩3.52bn | −₩51.54bn | −₩48.92bn | −₩23.87bn | −₩15.90bn | −₩9.84bn | −₩37.59bn | ₩6.91bn | −₩8.58bn | −₩2.18bn |
| Diluted earnings per share | -98.08 | -1,435.75 | -1,362.75 | -664.86 | -442.91 | -274.03 | -1,046.93 | 192.41 | -238.87 | -60.71 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩224.11bn | ₩260.47bn | ₩243.12bn | ₩322.61bn | ₩332.93bn | ₩316.96bn | ₩379.19bn | ₩256.92bn | ₩119.47bn | ₩128.67bn |
| Cash and short-term investments | — | ₩53.44bn | — | ₩81.92bn | ₩122.50bn | ₩139.16bn | ₩148.60bn | ₩158.59bn | ₩30.65bn | ₩25.42bn |
| Total liabilities | ₩105.43bn | ₩161.95bn | ₩97.82bn | ₩134.34bn | ₩125.09bn | ₩102.20bn | ₩230.14bn | ₩72.45bn | ₩27.88bn | ₩45.51bn |
| Debt | — | ₩49.30bn | ₩29.74bn | ₩64.65bn | ₩62.44bn | ₩52.44bn | ₩54.45bn | ₩32.29bn | ₩13.00bn | ₩15.38bn |
| Shareholders' equity | ₩105.15bn | ₩98.52bn | ₩145.29bn | ₩188.28bn | ₩207.84bn | ₩214.76bn | ₩149.05bn | ₩184.47bn | ₩91.59bn | ₩83.16bn |
| Shares outstanding | 36m | 36m | 36m | 36m | 36m | 36m | 36m | 36m | 36m | 36m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩17.41bn | −₩25.85bn | −₩32.41bn | −₩24.40bn | −₩11.46bn | −₩16.38bn | −₩7.14bn | −₩1.21bn | ₩1.63bn | −₩8.30bn |
| Capital spending | −₩7.99bn | −₩9.94bn | −₩23.56bn | −₩14.68bn | −₩10.61bn | −₩6.75bn | −₩618.3m | −₩293.4m | −₩10.74bn | −₩704.3m |
| Free cash flow | −₩25.41bn | −₩35.79bn | −₩55.97bn | −₩39.08bn | −₩22.07bn | −₩23.13bn | −₩7.76bn | −₩1.50bn | −₩9.10bn | −₩9.01bn |
| Dividends paid | — | −₩2.52bn | — | — | — | −₩1.30bn | −₩1.30bn | −₩1.30bn | −₩1.30bn | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩4.61bn | ₩4.29bn | ₩12.00bn | ₩6.13bn | ₩3.73bn | ₩3.08bn | ₩2.74bn | ₩1.63bn |
| Operating income | −₩6.55bn | −₩6.10bn | — | −₩6.99bn | −₩9.31bn | −₩5.18bn | −₩36.48bn | −₩6.68bn |
| Net income | −₩6.65bn | −₩4.47bn | ₩23.76bn | −₩12.21bn | −₩10.30bn | −₩4.77bn | −₩22.40bn | −₩7.38bn |
| Diluted earnings per share | -185.23 | -124.57 | 661.86 | -340.11 | -287.02 | -132.81 | -624.02 | -205.45 |
| Cash from operations | ₩4.16bn | −₩4.72bn | ₩8.58bn | −₩11.39bn | −₩10.03bn | −₩4.58bn | −₩25.85bn | −₩16.40bn |
| Capital spending | −₩11.42bn | −₩832.0m | −₩4.78bn | −₩627.0m | −₩1.15bn | −₩1.44bn | −₩9.94bn | −₩10.36bn |
| Free cash flow | −₩7.26bn | −₩5.55bn | ₩3.81bn | −₩12.02bn | −₩11.18bn | −₩6.01bn | −₩35.79bn | −₩26.76bn |
| Total assets | ₩220.05bn | ₩216.86bn | ₩224.11bn | ₩212.20bn | ₩244.84bn | ₩252.12bn | ₩260.47bn | ₩227.02bn |
| Cash and short-term investments | — | — | — | — | — | ₩44.25bn | ₩53.44bn | ₩38.87bn |
| Debt | — | — | — | — | — | ₩14.43bn | ₩49.30bn | ₩35.94bn |
| Shareholders' equity | ₩94.02bn | ₩100.68bn | ₩105.15bn | ₩68.13bn | ₩80.45bn | ₩93.83bn | ₩98.52bn | ₩117.34bn |
Financial ratios
Data as of 8 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -95.3% | -757.9% | -327.6% | -565.1% | -57.3% | 26.2% | — | — |
| Net margin | -12.9% | -710.6% | -1002.8% | -552.4% | -37.5% | -32.6% | — | — |
| Return on equity | -3.3% | -52.3% | -33.7% | -12.7% | -7.7% | -4.6% | — | — |
| Return on assets | -1.6% | -19.8% | -20.1% | -7.4% | -4.8% | -3.1% | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | 36.0% |
| Revenue growth | 277.6% | 48.7% | 12.9% | -89.8% | 40.2% | 115.8% | — | — |
| Earnings growth | -93.2% | 5.4% | 105.0% | 50.1% | 61.6% | -73.8% | — | — |
| Current ratio | 0.51x | 0.95x | 1.02x | 1.22x | 2.18x | 2.30x | — | — |
| Debt to equity | — | 0.50x | 0.20x | 0.34x | 0.30x | 0.24x | 0.36x | — |
| Equity ratio | 46.9% | 37.8% | 59.8% | 58.4% | 62.4% | 67.8% | — | — |
| Interest coverage | -6.11x | -15.81x | -7.63x | -10.72x | -9.97x | 1.38x | — | — |
| R&D as a share of sales | 16.2% | 156.0% | 147.2% | 146.8% | 11.5% | 16.5% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 85.1% | -1.9% | 16.1% |
| Operating income | 2.2% | — | 20.7% |
| Net income | -47.2% | -18.6% | -3.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -234.0% | -277.0% | -118.4% | -95.1% |
| Net margin | -158.9% | -291.6% | -131.9% | -112.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -15.2 | -1.7 | -2.0 | -5.3 | -14.9 | -43.5 | -9.4 | 59.9 | -49.8 | -140.4 |
| Price to sales | 1.9 | 11.9 | 20.4 | 29.1 | 5.6 | 14.2 | 25.3 | 29.8 | 35.1 | 21.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 3-for-2 split · 1 Apr 2021
- 13-for-10 split · 10 Jul 2018
- 13-for-10 split · 29 Apr 2011
- 13-for-10 split · 26 Nov 2007
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.